Clinical Reviews in Allergy & Immunology

, Volume 33, Issue 1–2, pp 85–106 | Cite as

Pathophysiology of Cutaneous Lupus Erythematosus

  • Julie H. Lin
  • Jan P. Dutz
  • Richard D. Sontheimer
  • Victoria P. Werth
Article

Abstract

Cutaneous lupus erythematosus (LE; syn LE-specific skin disease) is an autoimmune disease with well-defined skin manifestations often accentuated in a photodistribution and frequently associated with specific autoantibodies. These clinical observations have led to numerous laboratory studies related to the role of ultraviolet light, as well as studies of the cascade of immunologic events involved in the pathogenesis of cutaneous LE. We discuss the epidemiologic, clinical, and laboratory findings of cutaneous LE, including the classification of disease subsets. We review the evidence for abnormal photoreactivity in LE with an overview of the cellular, molecular, and genetic factors that may underlie this abnormality. As there is yet no convincing animal model of cutaneous LE, many studies remain descriptive in nature. To arrive at an understanding of the potential mechanisms underlying the development of cutaneous lupus, we discuss the role of ultraviolet light-mediated induction of apoptosis, antigen presentation, genetic factors, and mediators of inflammation. In addition, we consider the role and importance of humoral and cellular factors, synthesizing the current understanding of the pathophysiology of cutaneous lupus.

Keywords

Cutaneous lupus erythematosus Photosensitivity Autoimmune disease Apoptosis 

References

  1. 1.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedGoogle Scholar
  2. 2.
    Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6:96–104PubMedGoogle Scholar
  3. 3.
    Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR (1992) Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum. 21:221–226PubMedGoogle Scholar
  4. 4.
    Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60:105–113PubMedGoogle Scholar
  5. 5.
    Lee C, Kim J (1997) Clinical features of subacute cutaneous lupus erythematosus among Korean patients with lupus erythematosus. Kor J Dermatol 35:82–87Google Scholar
  6. 6.
    Sontheimer R (1989) Subacute cutaneous lupus erythematosus: a decade’s perspective. Med Clin North Am 73:1073–1090PubMedGoogle Scholar
  7. 7.
    Werth VP (2005) Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev 4:296–302PubMedGoogle Scholar
  8. 8.
    Petri M (2005) Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 31:245–54, viPubMedGoogle Scholar
  9. 9.
    Albrecht J, Berlin JA, Braverman IM, Callen JP, Connolly MK, Costner MI, Dutz J, Fivenson D, Franks AG, Jorizzo JL, Lee LA, McCauliffe DP, Sontheimer RD, Werth VP (2004) Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 13:839–849PubMedGoogle Scholar
  10. 10.
    Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115:1409–1415PubMedGoogle Scholar
  11. 11.
    Sontheimer RD (2005) Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 4:253–263PubMedGoogle Scholar
  12. 12.
    Petri M (1998) Dermatologic lupus: Hopkins lupus cohort. Semin Cutan Med Surg 17:219–227PubMedGoogle Scholar
  13. 13.
    Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stastny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97:664–671PubMedGoogle Scholar
  14. 14.
    Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR (1991) Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 21:55–64PubMedGoogle Scholar
  15. 15.
    Wallace DJ, Lyon I (1999) Pierre Cazenave and the first detailed modern description of lupus erythematosus. Semin Arthritis Rheum 28:305–313PubMedGoogle Scholar
  16. 16.
    Kesten BM, Slatkin M (1953) Diseases related to light sensitivity. AMA Arch Derm Syphilol 67:284–301PubMedGoogle Scholar
  17. 17.
    Epstein JH, Tuffanelli D, Dubois EL (1965) Light sensitivity and lupus erythematosus. Arch Dermatol 91:483–485PubMedGoogle Scholar
  18. 18.
    Baer RL, Harber LC (1965) Photobiology of lupus erythematosus. Arch Dermatol 92:124–128Google Scholar
  19. 19.
    Cripps DJ, Rankin J (1973) Action spectra of lupus erythematosus and experimental immunofluorescence. Arch Dermatol 107:563–567PubMedGoogle Scholar
  20. 20.
    Wolska H, Blaszczyk M, Jablonska S (1989) Phototests in patients with various forms of lupus erythematosus. Int J Dermatol 28:98–103PubMedGoogle Scholar
  21. 21.
    Doria A, Biasinutto C, Ghirardello A, Sartori E, Rondinone R, Piccoli A, Veller FC, Gambari PF (1996) Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition. Lupus 5:263–268PubMedGoogle Scholar
  22. 22.
    Sanders CJ, van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA (2003) Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149:131–137PubMedGoogle Scholar
  23. 23.
    Azizah MR, Azila MN, Zulkifli MN, Norita TY (1996) The prevalence of antinuclear, anti-dsDNA, anti-Sm and anti-RNP antibodies in a group of healthy blood donors. Asian Pac J Allergy Immunol 14:125–128PubMedGoogle Scholar
  24. 24.
    Hanvivatvong O, Tirawatnapong S, Kaowopas Y, Jitapankul S (2003) Prevalence of autoantibodies in Thai elderly. J Med Assoc Thai 86(Suppl 2):S242–S249PubMedGoogle Scholar
  25. 25.
    Vella FS, Orlando P, Attanasi F, Simone B, Mundo A, Lopalco P, Schiraldi O, Antonaci S (2001) Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events? Recenti Prog Med 92:107–112PubMedGoogle Scholar
  26. 26.
    Wasmuth HE, Stolte C, Geier A, Dietrich CG, Gartung C, Lorenzen J, Matern S, Lammert F (2004) The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 4:4PubMedGoogle Scholar
  27. 27.
    Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P (2005) Autoimmunity and anti-TNF-alpha agents. Ann N Y Acad Sci 1051:559–569PubMedGoogle Scholar
  28. 28.
    David-Bajar KM, Davis BM (1997) Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6:145–157PubMedGoogle Scholar
  29. 29.
    Ueki H, Wolff HH, Braun-Falco O (1974) Cutaneous localization of human gamma-globulins in lupus erythematosus. An electron-microscopical study using the peroxidase-labeled antibody technique. Arch Dermatol Forsch 248:297–314PubMedGoogle Scholar
  30. 30.
    Gilliam JN (1975) The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. J Invest Dermatol 65:154–161PubMedGoogle Scholar
  31. 31.
    Alahlafi AM, Wordsworth P, Wojnarowska F (2004) The lupus band: do the autoantibodies target collagen VII? Br J Dermatol 150:504–510PubMedGoogle Scholar
  32. 32.
    Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M (1994) The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 130:1262–1268PubMedGoogle Scholar
  33. 33.
    Pinkus H (1973), Lichenoid tissue reactions. A speculative review of the clinical spectrum of epidermal basal cell damage with special reference to erythema dyschromicum perstans. Arch Dermatol 107:840–846PubMedGoogle Scholar
  34. 34.
    de Jong EM, van Erp PE, Ruiter DJ, van de Kerkhof PC (1991) Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus. J Am Acad Dermatol 25:1032–1038PubMedGoogle Scholar
  35. 35.
    Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP (2005) The CLASI (cutaneous lupus erythematosus disease area and severity index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 125:889–894PubMedGoogle Scholar
  36. 36.
    Bonilla-Martinez Z, Albrecht J, Taylor L, Okawa J, Werth VP (2006) The CLASI (cutaneous le disease area and severity index): an outcome instrument for cutaneous lupus erythematosus. J Investig Dermatol 126:47–47Google Scholar
  37. 37.
    Freeman RG, Knox JM, Owens DW (1969) Cutaneous lesions of lupus erythematosus induced by monochromatic light. Arch Dermatol 100:677–682PubMedGoogle Scholar
  38. 38.
    Kochevar IE (1985) Action spectrum and mechanisms of UV radiation-induced injury in lupus erythematosus. J Invest Dermatol 85:140s–143sPubMedGoogle Scholar
  39. 39.
    Dowdy MJ, Nigra TP, Barth WF (1989) Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Arthritis Rheum 32:343–346PubMedGoogle Scholar
  40. 40.
    Fruchter O, Edoute Y (2005) First presentation of systemic lupus erythematosus following ultraviolet radiation exposure in an artificial tanning device. Rheumatology (Oxford) 44:558–559Google Scholar
  41. 41.
    Stern RS, Docken W (1986) An exacerbation of SLE after visiting a tanning salon. JAMA 255:3120Google Scholar
  42. 42.
    Lehmann P, Holzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181–187PubMedGoogle Scholar
  43. 43.
    Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45:86–95PubMedGoogle Scholar
  44. 44.
    Nived O, Johansen PB, Sturfelt G (1993) Standardized ultraviolet A exposure provokes skin reaction in systemic lupus erythematosus. Lupus 2:247–250PubMedGoogle Scholar
  45. 45.
    Wysenbeek AJ, Block DA, Fries JF (1989) Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis 48:461–463PubMedGoogle Scholar
  46. 46.
    Walchner M, Messer G, Kind P (1997) Phototesting and photoprotection in LE. Lupus 6:167–174PubMedGoogle Scholar
  47. 47.
    Krause I, Shraga I, Molad Y, Guedj D, Weinberger A (1997) Seasons of the year and activity of SLE and Behcet’s disease. Scand J Rheumatol 26:435–439PubMedCrossRefGoogle Scholar
  48. 48.
    Leone J, Pennaforte JL, Delhinger V, Detour J, Lefondre K, Eschard JP, Etienne JC (1997) Influence of seasons on risk of flare-up of systemic lupus: retrospective study of 66 patients. Rev Med Interne 18:286–291PubMedGoogle Scholar
  49. 49.
    Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 41:563–571Google Scholar
  50. 50.
    Zamansky GB, Chou IN (1990) Disruption of keratin intermediate filaments by ultraviolet radiation in cultured human keratinocytes. Photochem Photobiol 52:903–906PubMedGoogle Scholar
  51. 51.
    LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, Boyce ST, Kotzin BL, Weston WL (1984) Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 74:1545–1551PubMedGoogle Scholar
  52. 52.
    Golan TD, Elkon KB, Gharavi AE, Krueger JG (1992) Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 90:1067–1076PubMedGoogle Scholar
  53. 53.
    Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330PubMedGoogle Scholar
  54. 54.
    Casciola-Rosen L, Rosen A (1997) Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 6:175–180PubMedGoogle Scholar
  55. 55.
    Tan EM (1994) Autoimmunity and apoptosis. J Exp Med 179:1083–1086PubMedGoogle Scholar
  56. 56.
    Vaux DL (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90:786–789PubMedGoogle Scholar
  57. 57.
    Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131–136PubMedGoogle Scholar
  58. 58.
    Savill J (1998) Apoptosis. Phagocytic docking without shocking. Nature 392:442–443PubMedGoogle Scholar
  59. 59.
    Weedon D, Strutton G (1981) Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol 61:335–339PubMedGoogle Scholar
  60. 60.
    Budtz PE, Spies I (1989) Epidermal tissue homeostasis: apoptosis and cell emigration as mechanisms of controlled cell deletion in the epidermis of the toad, Bufo bufo. Cell Tissue Res 256:475–486PubMedGoogle Scholar
  61. 61.
    McCall CA, Cohen JJ (1991) Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 97:111–114PubMedGoogle Scholar
  62. 62.
    Seitz CS, Freiberg RA, Hinata K, Khavari PA (2000) NF-kappaB determines localization and features of cell death in epidermis. J Clin Invest 105:253–260PubMedGoogle Scholar
  63. 63.
    Norris DA, Whang K, David-Bajar K, Bennion SD (1997) The influence of ultraviolet light on immunological cytotoxicity in the skin. Photochem Photobiol 65:636–646PubMedGoogle Scholar
  64. 64.
    Daniels FJ (1961) Histochemical responses of human skin following ultraviolet radiation. 37:351–356Google Scholar
  65. 65.
    Godar DE (1999) UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 112:3–12PubMedGoogle Scholar
  66. 66.
    Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, Schwarz T (1998) Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 140:171–182PubMedGoogle Scholar
  67. 67.
    Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB (1999) Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 285:898–900PubMedGoogle Scholar
  68. 68.
    Qin JZ, Bacon P, Panella J, Sitailo LA, Denning MF, Nickoloff BJ (2004) Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis. J Cell Physiol 200:155–166PubMedGoogle Scholar
  69. 69.
    Schwarz A, Bhardwaj R, Aragane Y, Mahnke K, Riemann H, Metze D, Luger TA, Schwarz T (1995) Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 104:922–927PubMedGoogle Scholar
  70. 70.
    Zhuang L, Wang B, Shinder GA, Shivji GM, Mak TW, Sauder DN (1999) TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 162:1440–1447PubMedGoogle Scholar
  71. 71.
    Kulms D, Poppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T (1999) Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A 96:7974–7979PubMedGoogle Scholar
  72. 72.
    Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171PubMedGoogle Scholar
  73. 73.
    Takahashi H, Kinouchi M, Iizuka H (1997) Interleukin-1beta-converting enzyme and CPP32 are involved in ultraviolet B-induced apoptosis of SV40-transformed human keratinocytes. Biochem Biophys Res Commun 236:194–198PubMedGoogle Scholar
  74. 74.
    Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A, Lehmann P, Ruzicka T, Krammer PH, Kolb-Bachofen V (2006) Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 54:939–950PubMedGoogle Scholar
  75. 75.
    Chung JH, Kwon OS, Eun HC, Youn JI, Song YW, Kim JG, Cho KH (1998) Apoptosis in the pathogenesis of cutaneous lupus erythematosus. Am J Dermatopathol 20:233–241PubMedGoogle Scholar
  76. 76.
    Pablos JL, Santiago B, Galindo M, Carreira PE, Ballestin C, Gomez-Reino JJ (1999) Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol 188:63–68PubMedGoogle Scholar
  77. 77.
    Smith ML, Fornace AJ Jr (1997) p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci U S A 94:12255–12257PubMedGoogle Scholar
  78. 78.
    Brysk MM, Selvanayagam P, Arany I, Brysk H, Tyring SK, Rajaraman S (1995) Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes. J Interferon Cytokine Res 15:1029–1035PubMedGoogle Scholar
  79. 79.
    Tron VA, Trotter MJ, Tang L, Krajewska M, Reed JC, Ho VC, Li G (1998) p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes. Am J Pathol 153:579–585PubMedGoogle Scholar
  80. 80.
    Henkart PA (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343–346PubMedGoogle Scholar
  81. 81.
    Wright SC, Kumar P, Tam AW, Shen N, Varma M, Larrick JW (1992) Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48:344–355PubMedGoogle Scholar
  82. 82.
    Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650–652PubMedGoogle Scholar
  83. 83.
    Nakajima M, Nakajima A, Kayagaki N, Honda M, Yagita H, Okumura K (1997) Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin Immunol Immunopathol 83:223–229PubMedGoogle Scholar
  84. 84.
    Casciola-Rosen LA, Anhalt GJ, Rosen A (1995) DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 182:1625–1634PubMedGoogle Scholar
  85. 85.
    Utz PJ, Hottelet M, Schur PH, Anderson P (1997) Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 185:843–854PubMedGoogle Scholar
  86. 86.
    Utz PJ, Anderson P (1998) Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 41:1152–1160PubMedGoogle Scholar
  87. 87.
    Greidinger EL, Casciola-Rosen L, Morris SM, Hoffman RW, Rosen A (2000) Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 43:881–888PubMedGoogle Scholar
  88. 88.
    Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A (1999) Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 190:815–826PubMedGoogle Scholar
  89. 89.
    Berthou C, Michel L, Soulie A, Jean-Louis F, Flageul B, Dubertret L, Sigaux F, Zhang Y, Sasportes M (1997) Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J Immunol 159:5293–5300PubMedGoogle Scholar
  90. 90.
    Rosen A, Casciola-Rosen L (1999) Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 6:6–12PubMedGoogle Scholar
  91. 91.
    Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131–136PubMedGoogle Scholar
  92. 92.
    Roos A, Xu W, Castellano G, Nauta AJ, Garred P, Daha MR, van Kooten C (2004) Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34:921–929PubMedGoogle Scholar
  93. 93.
    Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525–4528PubMedGoogle Scholar
  94. 94.
    Eggleton P, Ward FJ, Johnson S, Khamashta MA, Hughes GR, Hajela VA, Michalak M, Corbett EF, Staines NA, Reid KB (2000) Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization. Clin Exp Immunol 120:384–391PubMedGoogle Scholar
  95. 95.
    Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ (1997) cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6:119–129PubMedGoogle Scholar
  96. 96.
    Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, Meyer PA, Walport MJ (1994) Hereditary C1q deficiency and systemic lupus erythematosus. QJM 87:455–464PubMedGoogle Scholar
  97. 97.
    Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59PubMedGoogle Scholar
  98. 98.
    Pickering MC, Fischer S, Lewis MR, Walport MJ, Botto M, Cook HT (2001) Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice. J Invest Dermatol 117:52–58PubMedGoogle Scholar
  99. 99.
    Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250PubMedGoogle Scholar
  100. 100.
    Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46:191–201PubMedGoogle Scholar
  101. 101.
    Okamoto H, Mizuno K, Itoh T, Tanaka K, Horio T (1999) Evaluation of apoptotic cells induced by ultraviolet light B radiation in epidermal sheets stained by the TUNEL technique. J Invest Dermatol 113:802–807PubMedGoogle Scholar
  102. 102.
    Woodcock A, Magnus IA (1976) The sunburn cell in mouse skin: preliminary quantitative studies on its production. Br J Dermatol 95:459–468PubMedGoogle Scholar
  103. 103.
    Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890–898PubMedGoogle Scholar
  104. 104.
    Nauta AJ, Castellano G, Xu W, Woltman AM, Borrias MC, Daha MR, van Kooten C, Roos A (2004) Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol 173:3044–3050PubMedGoogle Scholar
  105. 105.
    Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86–89PubMedGoogle Scholar
  106. 106.
    Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA (1998) Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 161:4467–4471PubMedGoogle Scholar
  107. 107.
    Caricchio R, McPhie L, Cohen PL (2003) Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol 171:5778–5786PubMedGoogle Scholar
  108. 108.
    Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–195PubMedGoogle Scholar
  109. 109.
    Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521PubMedGoogle Scholar
  110. 110.
    Bell DA, Maddison PJ (1980) Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 23:1268–1273PubMedGoogle Scholar
  111. 111.
    Scofield RH, Harley JB (1994) Association of anti-Ro/SS-A autoantibodies with glutamine in position 34 of DQA1 and leucine in position 26 of DQB1. Arthritis Rheum 37:961–962PubMedGoogle Scholar
  112. 112.
    McCauliffe DP, Faircloth E, Wang L, Hashimoto T, Hoshino Y, Nishikawa T (1996) Similar Ro/SS-A autoantibody epitope and titer responses in annular erythema of Sjogren’s syndrome and subacute cutaneous lupus erythematosus. Arch Dermatol 132:528–531PubMedGoogle Scholar
  113. 113.
    Miyagawa S, Shinohara K, Fujita T, Kidoguchi K, Fukumoto T, Hashimoto K, Yoshioka A, Shirai T (1997) Neonatal lupus erythematosus: analysis of HLA class II alleles in mothers and siblings from seven Japanese families. J Am Acad Dermatol 36:186–190PubMedGoogle Scholar
  114. 114.
    Rischmueller M, Lester S, Chen Z, Champion G, Van Den BR, Beer R, Coates T, McCluskey J, Gordon T (1998) HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren’s syndrome (pSS). Clin Exp Immunol 111:365–371PubMedGoogle Scholar
  115. 115.
    Namekawa T, Kuroda K, Kato T, Yamamoto K, Murata H, Sakamaki T, Nishioka K, Iwamoto I, Saitoh Y, Sumida T (1995) Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjogren’s syndrome. J Rheumatol 22:2092–2099PubMedGoogle Scholar
  116. 116.
    Reynolds P, Gordon TP, Purcell AW, Jackson DC, McCluskey J (1996) Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J Exp Med 184:1857–1870PubMedGoogle Scholar
  117. 117.
    Deshmukh US, Lewis JE, Gaskin F, Kannapell CC, Waters ST, Lou YH, Tung KS, Fu SM (1999) Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J Exp Med 189:531–540PubMedGoogle Scholar
  118. 118.
    Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA (1997) A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 40:2207–2211PubMedGoogle Scholar
  119. 119.
    Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW (2000) TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134PubMedGoogle Scholar
  120. 120.
    Bennion SD, Middleton MH, David-Bajar KM, Brice S, Norris DA (1995) In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 105:71S–79SPubMedGoogle Scholar
  121. 121.
    Middleton MH, Norris DA (1995) Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol 104:489–496PubMedGoogle Scholar
  122. 122.
    Werth VP, Zhang W, Dortzbach K, Sullivan K (2000) Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 115:726–730PubMedGoogle Scholar
  123. 123.
    Millard TP, Kondeatis E, Cox A, Wilson AG, Grabczynska SA, Carey BS, Lewis CM, Khamashta MA, Duff GW, Hughes GR, Hawk JL, Vaughan RW, McGregor JM (2001) A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 145:229–236PubMedGoogle Scholar
  124. 124.
    Clancy RM, Backer CB, Yin X, Chang MW, Cohen SR, Lee LA, Buyon JP (2004) Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis. Arthritis Rheum 50:2598–2603PubMedGoogle Scholar
  125. 125.
    Hoekzema R, Hannema AJ, Swaak TJ, Paardekooper J, Hack CE (1985) Low molecular weight C1q in systemic lupus erythematosus. J Immunol 135:265–271PubMedGoogle Scholar
  126. 126.
    Steinsson K, McLean RH, Merrow M, Rothfield NF, Weinstein A (1983) Selective complete Clq deficiency associated with systemic lupus erythematosus. J Rheumatol 10:590–594PubMedGoogle Scholar
  127. 127.
    Hannema AJ, Kluin-Nelemans JC, Hack CE, Eerenberg-Belmer AJ, Mallee C, van Helden HP (1984) SLE like syndrome and functional deficiency of C1q in members of a large family. Clin Exp Immunol 55:106–114PubMedGoogle Scholar
  128. 128.
    Rynes RI (1982) Inherited complement deficiency states and SLE. Clin Rheum Dis 8:29–47PubMedGoogle Scholar
  129. 129.
    Sontheimer RD, Racila E, Racila DM (2005) C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 125:14–23PubMedGoogle Scholar
  130. 130.
    Racila DM, Sontheimer CJ, Sheffield A, Wisnieski JJ, Racila E, Sontheimer RD (2003) Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 12:124–132PubMedGoogle Scholar
  131. 131.
    Miwa T, Maldonado MA, Zhou L, Sun X, Luo HY, Cai D, Werth VP, Madaio MP, Eisenberg RA, Song WC (2002) Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol 161:1077–1086PubMedGoogle Scholar
  132. 132.
    Gilchrest BA, Soter NA, Stoff JS, Mihm MC Jr (1981) The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol 5:411–422PubMedGoogle Scholar
  133. 133.
    Hruza LL, Pentland AP (1993) Mechanisms of UV-induced inflammation. J Invest Dermatol 100:35S–41SPubMedGoogle Scholar
  134. 134.
    Bennion SD, Norris DA (1997) Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 6:181–192PubMedGoogle Scholar
  135. 135.
    Kupper TS, Chua AO, Flood P, McGuire J, Gubler U (1987) Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 80:430–436PubMedGoogle Scholar
  136. 136.
    Granstein RD, Sauder DN (1987) Whole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. Lymphokine Res 6:187–193PubMedGoogle Scholar
  137. 137.
    Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA (1990) Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609–1614PubMedGoogle Scholar
  138. 138.
    Skiba B, Neill B, Piva TJ (2005) Gene expression profiles of TNF-alpha, TACE, furin, IL-1beta and matrilysin in UVA- and UVB-irradiated HaCat cells. Photodermatol Photoimmunol Photomed 21:173–182PubMedGoogle Scholar
  139. 139.
    de Vos S, Brach M, Budnik A, Grewe M, Herrmann F, Krutmann J (1994) Post-transcriptional regulation of interleukin-6 gene expression in human keratinocytes by ultraviolet B radiation. J Invest Dermatol 103:92–96PubMedGoogle Scholar
  140. 140.
    Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94:101S–107SPubMedGoogle Scholar
  141. 141.
    Kupper TS (1989) Mechanisms of cutaneous inflammation. Interactions between epidermal cytokines, adhesion molecules, and leukocytes. Arch Dermatol 125:1406–1412PubMedGoogle Scholar
  142. 142.
    Luger TA, Schwarz T (1990) Evidence for an epidermal cytokine network. J Invest Dermatol 95:100S–104SPubMedGoogle Scholar
  143. 143.
    Schroder JM (1995) Cytokine networks in the skin. J Invest Dermatol 105:20S–24SPubMedGoogle Scholar
  144. 144.
    Wang B, Fujisawa H, Zhuang L, Kondo S, Shivji GM, Kim CS, Mak TW, Sauder DN (1997) Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 159:6148–6155PubMedGoogle Scholar
  145. 145.
    Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252PubMedGoogle Scholar
  146. 146.
    Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T, Tuting T (2005) Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol 205:435–442PubMedGoogle Scholar
  147. 147.
    Meller S, Winterberg F, Gilliet M, Muller A, Lauceviciute I, Rieker J, Neumann NJ, Kubitza R, Gombert M, Bunemann E, Wiesner U, Franken-Kunkel P, Kanzler H., Dieu-Nosjean MC, Amara A, Ruzicka T, Lehmann P, Zlotnik A, Homey B (2005) Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 52:1504–1516PubMedGoogle Scholar
  148. 148.
    Grether-Beck S, Olaizola-Horn S, Schmitt H, Grewe M, Jahnke A, Johnson JP, Briviba K, Sies H, Krutmann J (1996) Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci USA 93:14586–14591PubMedGoogle Scholar
  149. 149.
    Morita A, Grewe M, Grether-Beck S, Olaizola-Horn S, Krutmann J (1997) Induction of proinflammatory cytokines in human epidermoid carcinoma cells by in vitro ultraviolet A1 irradiation. Photochem Photobiol 65:630–635PubMedGoogle Scholar
  150. 150.
    Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M, Grether-Beck S, Ruzicka T, Kapp A, Klotz LO, Sies H, Krutmann J (1997), Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet—a radiation phototherapy. J Exp Med 186:1763–1768PubMedGoogle Scholar
  151. 151.
    Heckmann M, Pirthauer M, Plewig G (1997) Adhesion of leukocytes to dermal endothelial cells is induced after single-dose, but reduced after repeated doses of UVA. J Invest Dermatol 109:710–715PubMedGoogle Scholar
  152. 152.
    Ullrich SE (1996) Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol 64:254–258PubMedGoogle Scholar
  153. 153.
    Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793PubMedGoogle Scholar
  154. 154.
    Belmont HM, Buyon J, Giorno R, Abramson S (1994) Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 37:376–383PubMedGoogle Scholar
  155. 155.
    McGrath H Jr, Bak E, Michalski JP (1987) Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black × New Zealand white)F1 hybrid mice. Arthritis Rheum 30:557–561PubMedGoogle Scholar
  156. 156.
    McGrath H, Martinez-Osuna P, Lee FA (1996) Ultraviolet-A1 (340–400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 5:269–274PubMedGoogle Scholar
  157. 157.
    Polderman MC, le Cessie S, Huizinga TW, Pavel S (2004) Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford) 43:1402–1404Google Scholar
  158. 158.
    Szegedi A, Simics E, Aleksza M, Horkay I, Gaal K, Sipka S, Hunyadi J, Kiss E (2005) Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44:925–931Google Scholar
  159. 159.
    Sanders CJ, Lam HY, Bruijnzeel-Koomen CA, Sigurdsson V, van Weelden H (2006) UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus. J Am Acad Dermatol 54:479–486PubMedGoogle Scholar
  160. 160.
    Weston WL, Harmon C, Peebles C, Manchester D, Franco HL, Huff JC, Norris DA (1982) A serological marker for neonatal lupus erythematosus. Br J Dermatol 107:377–382PubMedGoogle Scholar
  161. 161.
    Xue D, Shi H, Smith JD, Chen X, Noe DA, Cedervall T, Yang DD, Eynon E, Brash DE, Kashgarian M, Flavell RA, Wolin SL (2003) A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A 100:7503–7508PubMedGoogle Scholar
  162. 162.
    Clark G, Reichlin M, Tomasi TB Jr (1969) Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 102:117–122PubMedGoogle Scholar
  163. 163.
    Boulanger C, Chabot B, Menard HA, Boire G (1995) Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin Exp Immunol 99:29–36PubMedCrossRefGoogle Scholar
  164. 164.
    Alspaugh MA, Tan EM (1975) Antibodies to cellular antigens in Sjogren’s syndrome. J Clin Invest 55:1067–1073PubMedGoogle Scholar
  165. 165.
    Sontheimer RD, Lieu TS, McCauliffe DP (1991) Molecular characterization of the Ro/SS-A autoimmune response. Semin Dermatol 10:199–205PubMedGoogle Scholar
  166. 166.
    Farris AD, Puvion-Dutilleul F, Puvion E, Harley JB, Lee LA (1997) The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic RNAs: association with novel electron-dense bodies. Proc Natl Acad Sci U S A 94:3040–3045PubMedGoogle Scholar
  167. 167.
    O’Brien CA, Wolin SL (1994) A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 8:2891–2903PubMedGoogle Scholar
  168. 168.
    Ben Chetrit E, Chan EK, Sullivan KF, Tan EM (1988) A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 167:1560–1571PubMedGoogle Scholar
  169. 169.
    Gerl V, Hostmann B, Johnen C, Waka A, Gerl M, Schumann F, Klein R, Radbruch A, Hiepe F (2005) The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I. Arthritis Rheum 52:531–538PubMedGoogle Scholar
  170. 170.
    DiDonato F, Chan E, Askenase A (1999) Interaction between 52kD SSA/Ro and deubiquinating enzyme UNP; a clue to function (abstract). Arthritis Rheum 42:S109Google Scholar
  171. 171.
    Slobbe RL, Pluk W, Van Venrooij WJ, Pruijn GJ (1992) Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein–protein interactions. J Mol Biol 227:361–366PubMedGoogle Scholar
  172. 172.
    Scofield RH, Kurien BT, Zhang F, Mehta P, Kaufman K, Gross T, Bachmann M, Gordon T, Harley JB (1999) Protein–protein interaction of the Ro-ribonucleoprotein particle using multiple antigenic peptides. Mol Immunol 36:1093–1106PubMedGoogle Scholar
  173. 173.
    Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD (1996) Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol 156:4484–4491PubMedGoogle Scholar
  174. 174.
    Eggleton P, Reid KB, Kishore U, Sontheimer RD (1997) Clinical relevance of calreticulin in systemic lupus erythematosus. Lupus 6:564–571PubMedGoogle Scholar
  175. 175.
    Eggleton P, Llewellyn DH (1999) Pathophysiological roles of calreticulin in autoimmune disease. Scand J Immunol 49:466–473PubMedGoogle Scholar
  176. 176.
    Nair S, Wearsch PA, Mitchell DA, Wassenberg JJ, Gilboa E, Nicchitta CV (1999) Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. J Immunol 162:6426–6432PubMedGoogle Scholar
  177. 177.
    Gottlieb E, Steitz JA (1989) Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J 8:851–861PubMedGoogle Scholar
  178. 178.
    Holcik M, Korneluk RG (2000) Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol 20:4648–4657PubMedGoogle Scholar
  179. 179.
    Hendrick JP, Wolin SL, Rinke J, Lerner MR, Steitz JA (1981) Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol Cell Biol 1:1138–1149PubMedGoogle Scholar
  180. 180.
    Nguyen TO, Capra JD, Sontheimer RD (1996) Calreticulin is transcriptionally upregulated by heat shock, calcium and heavy metals. Mol Immunol 33:379–386PubMedGoogle Scholar
  181. 181.
    Kinoshita G, Purcell AW, Keech CL, Farris AD, McCluskey J, Gordon TP (1999) Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice. Clin Exp Immunol 115:268–274PubMedGoogle Scholar
  182. 182.
    Furukawa F, Ikai K, Matsuyoshi N, Shimizu K, Imamura S (1993) Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes. J Invest Dermatol 101:191–195PubMedGoogle Scholar
  183. 183.
    Igarashi T, Itoh Y, Fukunaga Y, Yamamoto M (1995) Stress-induced cell surface expression and antigenic alteration of the Ro/SSA autoantigen. Autoimmunity 22:33–42PubMedGoogle Scholar
  184. 184.
    Ellis J (1996) Stress proteins as molecular chaperones. Nature 328:378–379Google Scholar
  185. 185.
    Srivastava PK, Menoret A, Basu S, Binder RJ, McQuade KL (1998) Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8:657–665PubMedGoogle Scholar
  186. 186.
    Birk OS, Gur SL, Elias D, Margalit R, Mor F, Carmi P, Bockova J, Altmann DM, Cohen IR (1999) The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci U S A 96:5159–5163PubMedGoogle Scholar
  187. 187.
    Ghoreishi M, Katayama I, Yokozeki H, Nishioka K (1993) Analysis of 70 KD heat shock protein (HSP70) expression in the lesional skin of lupus erythematosus (LE) and LE related diseases. J Dermatol 20:400–405PubMedGoogle Scholar
  188. 188.
    Mamula MJ (1998) Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes. Immunol Rev 164:231–239PubMedGoogle Scholar
  189. 189.
    McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, Reynolds P, Gordon TP (1998) Determinant spreading: lessons from animal models and human disease. Immunol Rev 164:209–229PubMedGoogle Scholar
  190. 190.
    Kinoshita G, Keech CL, Sontheimer RD, Purcell A, McCluskey J, Gordon TP (1998) Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity. Lupus 7:7–11PubMedGoogle Scholar
  191. 191.
    Lieu TS, Sontheimer RD (1997) A subpopulation of WIL-2 cell calreticulin molecules is associated with RO/SS-A ribonucleoprotein particles. Lupus 6:40–47PubMedCrossRefGoogle Scholar
  192. 192.
    Scofield RH, Racila DM, Gordon TP, Kurien BT, Sontheimer RD (2000) Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein. J Rheumatol 27:128–134PubMedGoogle Scholar
  193. 193.
    Lee LA, Gaither KK, Coulter SN, Norris DA, Harley JB (1989) Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 83:1556–1562PubMedCrossRefGoogle Scholar
  194. 194.
    Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 94:77–85PubMedGoogle Scholar
  195. 195.
    Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA (1988) Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 141:1480–1488PubMedGoogle Scholar
  196. 196.
    Rosen A, Casciola-Rosen L, Ahearn J (1995) Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 181:1557–1561PubMedGoogle Scholar
  197. 197.
    Frisoni L, McPhie L, Colonna L, Sriram U, Monestier M, Gallucci S, Caricchio R (2005) Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity? J Immunol 175:2692–2701PubMedGoogle Scholar
  198. 198.
    Bennion SD, Ferris C, Lieu TS, Reimer CB, Lee LA (1990) IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. J Invest Dermatol 95:643–646PubMedGoogle Scholar
  199. 199.
    Biesecker G, Lavin L, Ziskind M, Koffler D (1982) Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus. N Engl J Med 306:264–270PubMedCrossRefGoogle Scholar
  200. 200.
    Helm KF, Peters MS (1993) Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus. J Am Acad Dermatol 28:687–691PubMedGoogle Scholar
  201. 201.
    Magro CM, Crowson AN, Harrist TJ (1996) The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br J Dermatol 134:855–862PubMedGoogle Scholar
  202. 202.
    Furukawa F, Kanauchi H, Imamura S (1994) Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology 189(Suppl 1):18–23PubMedGoogle Scholar
  203. 203.
    Furukawa F, Itoh T, Wakita H, Yagi H, Tokura Y, Norris DA, Takigawa M (1999) Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol 118:164–170PubMedGoogle Scholar
  204. 204.
    Niimi Y, Ioannides D, Buyon J, Bystryn JC (1995) Heterogeneity in the expression of Ro and La antigens in human skin. Arthritis Rheum 38:1271–1276PubMedGoogle Scholar
  205. 205.
    Ioannides D, Golden BD, Buyon JP, Bystryn JC (2000) Expression of SS-A/Ro and SS-B/La antigens in skin biopsy specimens of patients with photosensitive forms of lupus erythematosus. Arch Dermatol 136:340–346PubMedGoogle Scholar
  206. 206.
    Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN (1993) Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91:1687–1696PubMedGoogle Scholar
  207. 207.
    Furukawa F (1997) Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 6:193–202PubMedGoogle Scholar
  208. 208.
    Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR (2000) Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol 164:6046–6056PubMedGoogle Scholar
  209. 209.
    Mehling A, Loser K, Varga G, Metze D, Luger TA, Schwarz T, Grabbe S, Beissert S (2001) Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 194:615–628PubMedGoogle Scholar
  210. 210.
    Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5–8PubMedCrossRefGoogle Scholar
  211. 211.
    Ytterberg SR, Schnitzer TJ (1982) Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 25:401–406PubMedGoogle Scholar
  212. 212.
    Friedman RM, Preble O, Black R, Harrell S (1982) Interferon production in patients with systemic lupus erythematosus. Arthritis Rheum 25:802–803PubMedGoogle Scholar
  213. 213.
    Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J (1982) Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216:429–431PubMedGoogle Scholar
  214. 214.
    Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T (1987) Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 70:562–569PubMedGoogle Scholar
  215. 215.
    von Wussow P, Jakschies D, Hartung K, Deicher H (1988) Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 8:225–230Google Scholar
  216. 216.
    Savarese E, Chae OW, Trowitzsch S, Weber G, Kastner B, Akira S, Wagner H, Schmid RM, Bauer S, Krug A (2006) U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 107:3229–3234PubMedGoogle Scholar
  217. 217.
    Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202:1131–1139PubMedGoogle Scholar
  218. 218.
    Kind P, Lehmann P, Plewig G (1993) Phototesting in lupus erythematosus. J Invest Dermatol 100:53S–57SPubMedGoogle Scholar
  219. 219.
    Sontheimer R, Bergstresser PR (1982) Epidermal Langerhans cell involvement in cutaneous lupus erythematosus. J Invest Dermatol 79:237–243PubMedGoogle Scholar
  220. 220.
    Andrews BS, Schenk A, Barr R, Friou G, Mirick G, Ross P (1986) Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies. J Am Acad Dermatol 15:474–481PubMedCrossRefGoogle Scholar
  221. 221.
    Shiohara T, Moriya N, Tanaka Y, Arai Y, Hayakawa J, Chiba M, Nagashima M (1988) Immunopathologic study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells. J Am Acad Dermatol 18:67–74PubMedGoogle Scholar
  222. 222.
    Volc-Platzer B, Anegg B, Milota S, Pickl W, Fischer G (1993) Accumulation of gamma delta T cells in chronic cutaneous lupus erythematosus. J Invest Dermatol 100:84S–91SPubMedGoogle Scholar
  223. 223.
    Fivenson DP, Rheins LA, Nordlund JJ, Pomaranski M, Douglass MC, Krull EA (1991) Thy-1 and T-cell receptor antigen expression in mycosis fungoides and benign inflammatory dermatoses. J Natl Cancer Inst 83:1088–1092PubMedGoogle Scholar
  224. 224.
    Robak E, Niewiadomska H, Robak T, Bartkowiak J, Blonski JZ, Wozniacka A, Pomorski L, Sysa-Jedrezejowska A (2001) Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Mediators Inflamm 10:179–189PubMedGoogle Scholar
  225. 225.
    Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204:27–42PubMedGoogle Scholar
  226. 226.
    Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, Akira S, Kelly KM, Reeves WH, Bauer S, Krieg AM (2005) Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 202:1575–1585PubMedGoogle Scholar
  227. 227.
    Cruz PD Jr, Leverkus M, Dougherty I, Gleason MJ, Eller M, Yaar M, Gilchrest, BA (2000) Thymidine dinucleotides inhibit contact hypersensitivity and activate the gene for tumor necrosis factor alpha1. J Invest Dermatol 114:253–258PubMedGoogle Scholar
  228. 228.
    Yu P, Wellmann U, Kunder S, Quintanilla-Martinez L, Jennen L, Dear N, Amann K, Bauer S, Winkler TH, Wagner H (2006) Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol 18:1211–1219PubMedGoogle Scholar
  229. 229.
    Wu X, Peng SL (2006) Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54:336–342PubMedGoogle Scholar
  230. 230.
    Kelly KM, Zhuang H, Nacionales DC, Scumpia PO, Lyons R, Akaogi J, Lee P, Williams B, Yamamoto M, Akira S, Satoh M, Reeves WH (2006) “Endogenous adjuvant” activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. Arthritis Rheum 54:1557–1567PubMedGoogle Scholar
  231. 231.
    Norris DA (1993) Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 100:58S–68SPubMedGoogle Scholar
  232. 232.
    Lee LA, Farris AD (1999) Photosensitivity diseases: cutaneous lupus erythematosus. J Investig Dermatol Symp Proc 4:73–78PubMedGoogle Scholar
  233. 233.
    Orteu CH, Sontheimer RD, Dutz JP (2001) The pathophysiology of photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed 17:95–113PubMedGoogle Scholar
  234. 234.
    Werth VP, Dutz JP, Sontheimer RD (1997) Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus. Curr Opin Rheumatol 9:400–409PubMedGoogle Scholar
  235. 235.
    Sontheimer RD (1996) Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol 63:583–594PubMedGoogle Scholar
  236. 236.
    Werth VP, Bashir M, Zhang W (2004) Photosensitivity in rheumatic diseases. J Investig Dermatol Symp Proc 9:57–63PubMedGoogle Scholar
  237. 237.
    Sontheimer RD (1997) The lexicon of cutaneous lupus erythematosus—a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 6:84–95PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Julie H. Lin
    • 1
  • Jan P. Dutz
    • 2
  • Richard D. Sontheimer
    • 3
  • Victoria P. Werth
    • 1
    • 4
  1. 1.Department of DermatologyUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of Dermatology and Skin SciencesUniversity of British ColumbiaVancouver, British ColumbiaCanada
  3. 3.Department of DermatologyUniversity of Oklahoma Health Sciences CenterOklahoma CityUSA
  4. 4.Department of DermatologyPhiladelphia V.A. HospitalPhiladelphiaUSA

Personalised recommendations